Brainsonix is developing ultrasound-based neuromodulation technologies designed to influence brain activity without surgery or implants.
Related Posts
Health
Vitamin D in the Diet: Key Foods for Bone and Immune Health
November 6, 2025
Vitamin D in the Diet: Key Foods for Bone and Immune Health
Health
Health Benefits of Zinc and How to Get Enough from Diet
November 6, 2025
Health Benefits of Zinc and How to Get Enough from Diet
Blog
This paper described the design and operational framework of a clinically deployable low-intensity focused ultrasound pulsation system, the BrainSonix BX Pulsar 1002. The system was engineered explicitly for human neuromodulation, with an emphasis on calibration accuracy, reproducibility, and built-in safety controls rather than maximal acoustic output. At a time when many ultrasound systems were bespoke laboratory tools, this work articulated what was required for clinical-grade deployment. Key contributions included a single-element transducer architecture with well-characterized focal properties, defined operating envelopes, and real-time monitoring to ensure consistent delivery across sessions and operators. These design principles enabled the transition of focused ultrasound neuromodulation from experimental feasibility to scalable, multi-site clinical research. The BX Pulsar 1002 operationalized these concepts into a turnkey system, supporting standardized protocols and broader adoption across clinical and research settings.
January 6, 2026